SCHEMBL3948675

SCHEMBL3948675

COc1cc(CCO[Si](c2ccccc2)(c2ccccc2)C(C)(C)C)c(NC(=O)OC(C)(C)C)cn1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD9 Q9H8M2 1/20 0.35
MAPK1 P28482 1/20 0.34
BRD4 O60885 1/20 0.34
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
CNR2 P34972 1/20 0.33
AAK1 Q2M2I8 1/20 0.33
MAPT P10636 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
LMNA P02545 2/20 0.32
PABPC1 P11940 2/20 0.32
RXFP1 Q9HBX9 1/20 0.32
METAP1 P53582 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
CYP2C9 P11712 1/20 0.32
PTGER1 P34995 1/20 0.32
SCD O00767 1/20 0.32
NPC1 O15118 1/20 0.31
PKM P14618 1/20 0.31
MTNR1A P48039 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3944673 0.79 AAK1 (0.39) BRD9MEN1KMT2AAAK1MAPT
SCHEMBL8288755 0.78 ATR (0.34) MEN1KMT2AAAK1PABPC1METAP1
SCHEMBL3945475 0.77 EGFR (0.34) MAPTSMN1; SMN2LMNA
SCHEMBL15812122 0.77 AAK1 (0.37) BRD9BRD4MEN1KMT2ACNR2
SCHEMBL6217868 0.71 KMT2A (0.40) BRD9MEN1KMT2AAAK1MAPT
SCHEMBL29589580 0.71 KMT2A (0.40) BRD9MEN1KMT2AAAK1MAPT
SCHEMBL7681674 0.70 NNMT (0.47) BRD9MEN1KMT2AAAK1SMN1; SMN2
SCHEMBL29713519 0.70 NNMT (0.47) BRD9MEN1KMT2AAAK1SMN1; SMN2
SCHEMBL20095986 0.69 MEN1 (0.38) BRD9MEN1KMT2AAAK1MAPT
SCHEMBL12513167 0.69 ATR (0.38) BRD9MEN1KMT2AAAK1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009034546-A2 TRANS-DECAHYDROISOQUINOLINE DERIVATIVES ACTELION PHARMACEUTICALS LTD (CH) 2009-03-19 WO disclosed